KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Depreciation and Depletion (2016 - 2025)

Evolent Health has reported Depreciation and Depletion over the past 11 years, most recently at $6.3 million for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $6.3 million for Q4 2025, down 14.86% from a year ago — trailing twelve months through Dec 2025 was $26.3 million (down 13.2% YoY), and the annual figure for FY2025 was $26.3 million, down 13.2%.
  • Depreciation and Depletion for Q4 2025 was $6.3 million at Evolent Health, roughly flat from $6.3 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for EVH hit a ceiling of $8.9 million in Q4 2022 and a floor of $6.3 million in Q3 2025.
  • Median Depreciation and Depletion over the past 5 years was $7.6 million (2021), compared with a mean of $7.6 million.
  • Biggest five-year swings in Depreciation and Depletion: grew 14.71% in 2021 and later fell 18.99% in 2025.
  • Evolent Health's Depreciation and Depletion stood at $7.8 million in 2021, then increased by 14.1% to $8.9 million in 2022, then decreased by 14.61% to $7.6 million in 2023, then decreased by 2.63% to $7.4 million in 2024, then fell by 14.86% to $6.3 million in 2025.
  • The last three reported values for Depreciation and Depletion were $6.3 million (Q4 2025), $6.3 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.